To evaluate the feasibility and role of secondary surgery in ovarian cancer, a retrospective chart review was conducted on 98 patients treated for ovarian carcinoma at our institution between 1992 and 1996. Overall, 80 surgical procedures were performed in 68 patients: 4 patients (5%) underwent reassessment surgery following inappropriate primary surgical procedure; 20 patients (25%) in complete or partial response after first-line chemotherapy underwent interval debulking surgery; 42 patients (52%) without clinical evidence of disease at the completion of first-line chemotherapy underwent second-look laparotomy, and 14 of them received some kind of cytoreduction; 14 patients (18%) underwent cytoreductive surgery at the time of recurrent disease. Secondary surgery in its different forms is feasible in ovarian carcinoma and is associated with a low rate of complications. The proper indication for each of the multiple options for secondary surgery in ovarian carcinoma, however, still remains to be elucidated.

Secondary surgery in ovarian cancer: a 5-year experience.

CORMIO, Gennaro;LOVERRO, Giuseppe
1998-01-01

Abstract

To evaluate the feasibility and role of secondary surgery in ovarian cancer, a retrospective chart review was conducted on 98 patients treated for ovarian carcinoma at our institution between 1992 and 1996. Overall, 80 surgical procedures were performed in 68 patients: 4 patients (5%) underwent reassessment surgery following inappropriate primary surgical procedure; 20 patients (25%) in complete or partial response after first-line chemotherapy underwent interval debulking surgery; 42 patients (52%) without clinical evidence of disease at the completion of first-line chemotherapy underwent second-look laparotomy, and 14 of them received some kind of cytoreduction; 14 patients (18%) underwent cytoreductive surgery at the time of recurrent disease. Secondary surgery in its different forms is feasible in ovarian carcinoma and is associated with a low rate of complications. The proper indication for each of the multiple options for secondary surgery in ovarian carcinoma, however, still remains to be elucidated.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/129849
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact